Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-15

FDA Approved: ZONISADE — Original Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ZONISADE (zonisamide) via an original NDA for use in epilepsy, including partial-onset seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZONISADE

Snippet

ORIG AP for ZONISADE (ZONISAMIDE)